TargetMol

Memoquin

Product Code:
 
TAR-T25790
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T25790-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25790-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25790-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Memoquin is a multi-target-directed ligand for the therapy of Alzheimer's disease.
CAS:
616885-87-1
Formula:
C38H56N4O4
Molecular Weight:
632.89
Purity:
0.98
SMILES:
CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC

References

1. Pan W, Hu K, Bai P, Yu L, Ma Q, Li T, Zhang X, Chen C, Peng K, Liu W, Sang Z. Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem Lett. 2016 May 15;26(10):2539-2543. doi: 10.1016/j.bmcl.2016.03.086. Epub 2016 Mar 25. PubMed PMID: 27072909. 2. Page M, Pacico N, Ourtioualous S, Deprez T, Koshibu K. Procognitive Compounds Promote Neurite Outgrowth. Pharmacology. 2015;96(3-4):131-6. doi: 10.1159/000436974. Epub 2015 Jul 24. PubMed PMID: 26228694. 3. Prati F, Bartolini M, Simoni E, De Simone A, Pinto A, Andrisano V, Bolognesi ML. Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6254-8. doi: 10.1016/j.bmcl.2013.09.091. Epub 2013 Oct 5. PubMed PMID: 24140444. 4. Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A, Cavalli A. Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease. PLoS One. 2013;8(2):e56870. doi: 10.1371/journal.pone.0056870. Epub 2013 Feb 18. PubMed PMID: 23441223; PubMed Central PMCID: PMC3575497.